Sildenafil Studied in Women With Antidepressant-Associated Sexual Dysfunction

The table below compares Vyleesi and Addyi: Viagra is not FDA approved for use in females.

To understand why, it can help to understand what Viagra was designed to do in the male body.

What Are the Side Effects in Women?

Sildenafil citrate is metabolized is in the liver by cytochrome P450, the metabolites are: N-desmethylsildenafil (about 50% potency for PDE5). The biological half-life is from 3 to 4 hours, it is excreted in feces and in urine [4]. Sildenafil is developing as a potential applicant for the treatment of intrauterine growth retardation and for premature labor [5]. Sildenafil has also been proposed as a potential therapeutic strategy to maintain placental function in pre-eclampsia [6]. Should sildenafil citrate possess vasodilatory effects in the feto-placental circulation, this would significantly enhance its therapeutic use in treating placental insufficiency.

Addyi (filbanserin)

SC has recently been demonstrated not to alter the contractile response to vasoconstrictors or to endothelial dependent vasodilators. In non-pregnant females, SC causes uterine artery vasodilation therefore it also be employed to treat menstrual pain and muscle spasms [7]. SC is increasingly used in the pregnant patient for the treatment of pulmonary hypertension [8]. Its safety and efficacy combined with its lack of teratogenic or feto-toxic effects mean that its use for the treatment of pulmonary hypertension in pregnancy is likely to increase [9]. The most common adverse effects of sildenafil citrate use include: headache, flushing, indigestion, nasal congestion, and impaired vision, including photophobia and blurred vision.

Bupropion (Wellbutrin)

In July 2005, the FDA found that sildenafil could lead to vision impairment in rare cases [and several studies have linked sildenafil use with non-arteritic anterior ischemic optic neuropathy [10]. The FDA announced that all PDE5 inhibitors, including sildenafil, required a more prominent warning of the potential risk of sudden hearing loss [11]. Vaginal sildenafil might be an interesting therapeutic option before conception in women with histories of reproductive failure [12]. In addition, intravaginal sildenafil citrate tablets used as suppositories might be a new, interesting, safe antiabortive option in the treatment of threatened miscarriage in patients with a history of unexplained recurrent spontaneous abortion. The dose sildenafil 25 mg tablets intravaginal sildenafil citrate is 25 tablets given 3- 4 times daily [13]. Usually, after sexual stimulation in a male, there is a release of nitric oxide,

which increases levels of a regulatory agent in cells called cyclic guanosine monophosphate (cGMP).

This increase in cGMP causes smooth muscle relaxation, and it leads

Key takeaways:

Wareing M, Myers JE, O Hara M, Baker PN (2005) Sildenafil citrate (Viagra) enhances vasodilatation in fetal growth restriction. Zoma WD, Baker RS, Friedman A, Clark KE (2004) Sildenafil citrate (Viagra) increases uterine blood flow and potentiates estrogen-induced vasodilation. Webb DJ, Freestone S, Allen MJ, Muirhead, GJ (1999) “Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist”. (2007) A systematic review of experimental and clinical studies of sildenafil citrate for intrauterine growth restriction and pre-term labour. Roh CR, Budhraja V, Kim HS, Nelson DM, Sadovsky Y (2005) “Microarraybased identification of differentially expressed genes in hypoxic term human trophoblasts and in placental villi of pregnancies with growth restricted fetuses,” Placenta 26(4): 319-328.

Can Viagra make a woman wet?

(2004) Hypothesis: selective phosphodiesterase-5 inhibition improves outcome in preeclampsia. Warnes CA (2004) Pregnancy and pulmonary hypertension. Sher G, Fisch JD (2002) Effect of vaginal sildenafil on the outcome of in vitro fertilization (IVF) after multiple IVF failures attributed to poor endometrial development. (2001) “Monitoring of fetuses with intrauterine growth restriction: a longitudinal study,” Ultrasound Obstet Gynecol 18 (6): 564-570. Jerzak M, Kniotek M, Mrozek J, Baranowski W (2008) Sildenafil citrate decreased natural killer cell activity and enhanced chance of successful pregnancy in women with a history of recurrent miscarriage.

Bremelanotide (Vyleesi)

El Far M, El Motwally Ael G, Hashem IA, Bakry N (2009) Biochemical role of intravaginal sildenafil citrate as a novel antiabortive agent in unexplained recurrent spontaneous miscarriage: first clinical study of four case reports from Egypt. (2009) A randomised, double-blinded, placebo-controlled study of the phosphodiesterase type 5 inhibitor sildenafil for the treatment of preeclampsia. Kaplan SA, Reis RB, Kohn IJ (1999) Safety and efficacy of sildenafil in postmenopausal women with sexual dysfunction. Basson R, McInnes R, Smith MD (2000) Efficacy and safety of sildenafil in estrogenized women with sexual dysfunction associated with female sexual arousal disorder. Rosen R, Riley A, Wagner G (1999) The international index of erectile function (IIEF): A multidimensional scale for assessment of erectile dysfunction. to increased blood flow to the penis, resulting in an erection.

• Female patients should be cautious with sildenafil due to lack of approval.
• Erectile dysfunction medications can interact with other drugs, affecting women as well.
• Some studies suggest sildenafil may help women with arousal issues but are inconclusive.
• Sildenafil may improve clitoral blood flow, enhancing sensitivity.
• Libido enhancement from sildenafil varies based on individual health factors.
• Self-medicating women with sildenafil without supervision can be risky.

In males, an erection goes down when an enzyme called phosphodiesterase type 5 (PDE-5) breaks down. Anyone who would like to try Viagra should ask a medical professional, who may prescribe the drug off-label.

Materials and Methods:

(2011) Sexual dysfunction and difficulties in Denemark: Prevelance and associated socio-demographic factors. Arch sex behave 40(1): 121-132. Abdallah I Y, AbdelrahmanSh (2014) female sexual dysfunction in relation to the age of marriage .thesis submitted for fulfillment of master degree in dermatology and Andrology in Banha city, Banha University, Egypt. Omidi A, Ahmedvand A, Najarzadan MR, Mehrzad F (2016) Compairing the effect of treatment with sildenafil and cognitive-behavioral therapy on treatment of sexual dysfunctioninwomen: arandomized controlled clinical trials. Chivers MI, Rosen RC (2010) Phosphodiesterase type 5 and female sexual response.

Drug information

J Sex Med 7(2): 858-872. Leddy LS, Yang CC, Stuckey BG, Sudworth M, Haughie S, et al. (2012) Influence of sildenafil on genital engorgement in women with female sexual arousal disorder. Sildenafil increases serum testosterone levels by a direct action on the testes. Lo Monte G, Graziano A, Piva I, Marci R (2014) Women taking the blue pill (sildenafil citrate) such big deal.

Mohamed Alhefnawy1*, Abdulla Esawy2, Mohamed Abdelazeem1, Mohamed Elnamoury3, Ahmed Eissa4, Ahmed Zoair4, Ahmed Ghaith4, Ayman Hagras4 and Khaled Almekaty4

(1999) Safety and efficacy of sildenafil in postmenopausal women with female sexual dysfunction. Email Us: info@lupinepublishers.com Call Us: +1 (914) 407-6109 57 West 57th Street, 3rd floor, New York - NY 10019, USA Department of Obstetrics & Gynecology, Tanta University, Egypt Received: October 03, 2018; Published: October 09, 2018 Corresponding author: Mohamed Nabih EL-Gharib, Professor of Obstetrics & Gynecology, Faculty of Medicine, Tanta University, Egypt Sildenafil citrate (SC) is a medicinal drug used to treat male erectile dysfunction and pulmonary hypertension. Sildenafil is a selective and potent competitive inhibitor of the cyclic guanosine monophosphate (cGMP) -specific phosphodiesterase-type 5 (PDE-5) enzymes, which, by preventing the breakdown of cGMP, potentiate the action of NO in tissues that contain PDE-5. Thus, increasing vasodilatation and potentiating the effects of nitrous oxide (NO) on the vascular smooth muscle [1-2]. SC increases uterine blood flow and potentiates estrogen-induced vasodilatation [3]. Vyleesi targets melanocortin receptors, which are linked to sexual function.

Other Treatments for Low Libido

It can take no more than 8 weeks to see an increase in sexual desire, though some people experience the effects much sooner. The FDA states that Vyleesi medication can treat FSIAD in premenopausal females. A person injects it into their thigh or stomach at least 45 minutes before having sex. The effects can last for up to 24 hours. People should not use the drug more than eight times per month. The drug modulates the brain pathways involved in sexual response.

Efficacy of Sildenafil Citrate on Female Sexual Dysfunction in A Sample of Egyptian Females, A Prospective Placebo Controlled Study

Mark E SmithBio chemistryUniversity of Texas Medical Branch, USA Lawrence A PresleyDepartment of Criminal JusticeLiberty University, USA Thomas W MillerDepartment of PsychiatryUniversity of Kentucky, USA Gjumrakch AlievDepartment of MedicineGally International Biomedical Research & Consulting LLC, USA Christopher BryantDepartment of Urbanisation and AgriculturalMontreal university, USA Robert William FrareOral & Maxillofacial PathologyNew York University, USA Rudolph Modesto NavariGastroenterology and HepatologyUniversity of Alabama, UK Andrew HagueDepartment of MedicineUniversities of Bradford, UK George Gregory ButtigiegMaltese College of Obstetrics and Gynaecology, Europe Emilio Bucio-CarrilloRadiation ChemistryNational University of Mexico, USA Casey J GrenierAnalytical ChemistryWentworth Institute of Technology, USA Hany AtalahMinimally Invasive SurgeryMercer University school of Medicine, USA Abu-Hussein MuhamadPediatric DentistryUniversity of Athens , Greece The annual scholar awards from Lupine Publishers honor a selected number Read More.. In the United States, two drugs have been approved to treat female sexual interest/arousal disorder (FSIAD): Vyleesi (bremelanotide) and Addyi (flibanserin). Some people may refer to these as “Viagra for females.” The Food and Drug Administration (FDA) have approved two drugs — flibanserin (Addyi) and bremelanotide (Vyleesi) — to address low desire or arousal in females. However, both are approved for use only in people who have not yet entered menopause. This article describes the FDA-approved medications for low libido in females, including how they work and the possible side effects.

Exploratory Phase 2b RESPOND Study, Completed in 2023

This article will use the terms “male,” “female,” or both to refer to sex assigned at birth. The FDA has approved two drugs to address FSIAD: Vyleesi (bremelanotide) and Addyi (flibanserin). Addyi was the first drug approved to treat FSIAD. Addyi is designed for premenopausal people, and is available as a pill. A person takes this drug daily before bed, even if they do not intend to have sex that day. After 3 days of taking the medication, there is a steady level of the drug in the body.

• Awareness of sildenafil's potential side effects helps women make informed choices.
• Women should avoid using sildenafil with nitrates to prevent dangerous drops in blood pressure.
• Proper diagnosis of sexual dysfunction can guide appropriate treatment options.
• Scientific research continues to explore safer, women-specific sexual health drugs.
• Sildenafil’s long-term effects on women are not yet fully understood.
• Healthcare providers can help determine if sildenafil is appropriate for individual cases.